Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction

Jacob A. Doll, Tracy Y. Wang, Niteesh K. Choudhry, Christopher P. Cannon, David J. Cohen, Gregg C. Fonarow, Timothy D. Henry, Durgesh D. Bhandary, Naeem Khan, Linda D. Davidson-Ray, Kevin Anstrom, Eric D. Peterson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y<sub>12</sub> receptor inhibitor copayment reduction after myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences